Skip to main navigation
Skip to search
Skip to main content
Region Zealand Home
Help & FAQ
Link opens in a new tab
Dansk
English
Search content at Region Zealand
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Courses
Press/Media
Impacts
Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer’s disease: a systematic review
Svend Ubbe Ebbesen
*
,
Peter Høgh
, Ivan Chrilles Zibrandtsen
*
Corresponding author for this work
Emergency (NFS)
Neurology
Research output
:
Contribution to journal
›
Review
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Explore the research areas of 'Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer’s disease: a systematic review'.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Cerebrospinal Fluid
100%
Early Prognosis
100%
Biomarkers for Early Diagnosis
100%
Alzheime's Disease
100%
95% Confidence Interval
28%
Dementia
14%
Validation Studies
14%
PubMed
14%
Meta-analysis
14%
Diagnostic Biomarker
14%
Most Common Cause
14%
Measurement Study
14%
Measurement Method
14%
Biomarker Analysis
14%
Plasma Biomarkers
14%
Cerebrospinal Fluid Biomarkers
14%
Neuroscience
Alzheimer's Disease
100%
Blood Plasma
100%
Systematic Review
100%
Biological Marker
100%
Positron Emission Tomography
60%
Amyloid Protein
60%
Meta-Analysis
10%
Amyloid Beta
10%
Immunology and Microbiology
Blood Plasma
100%
Alzheimer's Disease
100%
Cerebrospinal Fluid
80%
Medline
10%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Amyloid Protein
60%
Clinical Study
20%
Medline
10%
Amyloid Beta
10%
Diagnostic Biomarker
10%